CHEMECA DRUGS PRIVATE LTD (India) holds 13 active US FDA Type II Drug Master Files, has DMF or CEP filings on record for 13 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “CHEMECA DRUGS PRIVATE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/chemeca-drugs-private-ltd

Overview

CHEMECA DRUGS PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 12 active FDA Type II Drug Master Files, covering BUPROPION HYDROCHLORIDE USP; CARISOPRODOL USP; CELECOXIB USP; CLOPIDOGREL BISULFATE USP; DILTIAZEM HYDROCHLORIDE USP; FEXOFENADINE HYDROCHLORIDE USP.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which CHEMECA DRUGS PRIVATE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

CHEMECA DRUGS PRIVATE LTD holds 13 active (13 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • CARIPRAZINE HYDROCHLORIDEActive2026-09-23
  • FLUOXETINE HYDROCHLORIDE USPActive2025-09-30
  • RIFAXIMINActive2025-09-19
  • PIRFENIDONE USPActive2024-09-30
  • HYDRALAZINE HCL USPActive2023-09-13
  • CELECOXIB USPActive2023-01-12
  • QUETIAPINE FUMARATE USPActive2022-07-26
  • FEXOFENADINE HYDROCHLORIDE USPActive2021-12-15
  • CLOPIDOGREL BISULFATE USPActive2021-02-05
  • BUPROPION HYDROCHLORIDE USPActive2020-12-24
  • CARISOPRODOL USPActive2020-09-28
  • DILTIAZEM HYDROCHLORIDE USPActive2020-02-15
  • SERTRALINE HYDROCHLORIDE USPActive2019-03-01

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to CHEMECA DRUGS PRIVATE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHEMECA DRUGS PRIVATE LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this CHEMECA DRUGS PRIVATE LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.